13Indexed trials
drug · Product Intelligence
Carboplatin
Pipeline Intelligence
Carboplatin: 13 indexed trials, 4 sponsors; 0 linked Orange Book patents and 6 FDA-linked events where matched.
4Sponsors
0Orange Book patent links
6FDA-linked events
Development evidence
NCT01445119Eli Lilly and Company · neuro_oncologyPHASE1
NCT02622074Merck Sharp & Dohme LLC · parkinsonsPHASE1
NCT02964013Merck Sharp & Dohme LLC · parkinsonsPHASE1
NCT03066778Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT03348904Incyte Corporation · parkinsonsPHASE3
NCT03358472Incyte Corporation · parkinsonsPHASE3
NCT04191135Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT06647563Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · parkinsonsPHASE3
NCT06788912Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT06952504Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT06966700Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT07216703Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT07252739Merck Sharp & Dohme LLC · parkinsonsPHASE2
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALCARBOPLATIN · 2007-04-24
FDA_APPROVALCARBOPLATIN · 2007-01-18
FDA_APPROVALCARBOPLATIN · 2005-09-21
FDA_APPROVALCARBOPLATIN · 2004-10-14
FDA_APPROVALCARBOPLATIN · 2004-10-14
FDA_APPROVALPARAPLATIN · 2003-07-14
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.